Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Bevacizumab (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 34
» View wsbt.com items only
    May 24, 2012 |Story| AP Broadcast

  1. Senate bill aims to increase drug import safety

    WASHINGTON (AP) — U.S. regulators would inspect more drug manufacturing facilities in China, India and other foreign countries as part of legislation approved Thursday that aims to step up oversight of the nation's imported pharmaceutical supply....

    Tags: Chemical Industry, China, Allergies, Punishment, Science and Technology

    2. May 10, 2013 |Story| Reuters

  2. RPT-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices

    Reuters
    (Repeats to widen readership) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc...

    Tags: Chemical Industry, Government, Environmental Issues, Science and Technology, Culture

    3. May 10, 2013 |Story| Reuters

  3. XxANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices

    Reuters
    By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and AstraZeneca have grown...

    Tags: Government, Chemical Industry, Environmental Issues, Science and Technology, Plavix (drug)

    4. May 10, 2013 |Story| Reuters

  4. REFILE-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices

    Reuters
    (Removes "XX" from headline) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and...

    Tags: Government, Chemical Industry, Environmental Issues, Science and Technology, Plavix (drug)

    5. Apr 19, 2013 |Story| Los Angeles Times

  5. Strategies for cutting the cost of prescription drugs

    When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it.
    When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it. The 59-year-...

    Tags: Chemical Industry, Ovarian Cancer, High Blood Pressure, Herceptin (drug), National Institutes of Health

    6. Apr 23, 2013 |Story| Los Angeles Times

  6. Cancer drug may double as fat-busting treatment for obesity

    Way back in 2002, Dr. Judah Folkman hit upon a tantalizing weight-loss strategy for obese mice. When given daily injections of a drug designed to fight cancer, their fat melted away. The higer the dose they got, the more fat they lost. Some of the obese mice shed so much weight that they wound up at &ldquo;near normal body weights,&rdquo; Folkman and his colleagues reported <a href="http://www.pnas.org/content/99/16/10730.full.pdf">in this article</a> in Proceedings of the National Academy of Sciences.
    Way back in 2002, Dr. Judah Folkman hit upon a tantalizing weight-loss strategy for obese mice. When given daily injections of a drug designed to fight cancer, their fat melted away. The higer the dose they got, the more fat they lost. Some of the obese...

    Tags: Science and Technology, Obesity, Research, University of Mississippi, Medical Research

    7. Mar 29, 2013 |Story| Los Angeles Times

  7. Remove Medicare's straitjacket

    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although raising the age of Medicare eligibility from 65 to 67 appears off the table, at least for now, the budget plan that Rep. Paul D. Ryan (R-Wis.) is proposing would shift a greater share of the program's growing costs to beneficiaries in the years to come.
    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although...

    Tags: Chemical Industry, Amgen Inc., Dialysis, Healthcare Industry, Science and Technology

    8. Feb 19, 2013 |Story| Reuters

  8. Almost one-third of chemotherapy used 'off-label'

    NEW YORK (Reuters Health) - About one-third of chemotherapies are used to fight cancers that drug regulators never approved them to treat, says a new study.
    Reuters
    NEW YORK (Reuters Health) - About one-third of chemotherapies are used to fight cancers that drug regulators never approved them to treat, says a new study. Chemotherapies - drugs that kill rapidly dividing cells - are approved by the Food and Drug...

    Tags: Biotechnology, University of Chicago, Science and Technology, Health and Safety at School, Harvard Medical School

    9. Dec 13, 2012 |Story| Reuters

  9. More pressure to justify cost of cancer drugs versus benefits

    (Reuters) - Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments.
    Reuters
    (Reuters) - Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments. In the past, pharmaceutical companies could launch a high-priced drug with little push back. But now, there...

    Tags: Chemical Industry, Biotechnology, Science and Technology, Healthcare Provider, Prices

    10. Oct 16, 2012 |Story| Chicago Tribune

  10. Fake medicine poses growing threat to consumers

    Consumers shopping for medicine on the Internet often are getting convenience, a good price and the cloak of privacy, but they may not be getting the real thing. A burgeoning multibillion-dollar industry of counterfeit drugs — ranging from AIDS...

    Tags: Chemical Industry, Health and Personal Care, Science and Technology, CVS Corp., AIDS

    11. Oct 27, 2012 |Story| Los Angeles Times

  11. For the record

    Medical study results: In the Oct. 24 Section A, an article about medical studies said that follow-up studies of the drug Avastin showed that it did not help breast cancer patients live longer with their disease without getting worse. Those studies did...

    Tags: Sports, Football, Breast Cancer

    12. Jul 17, 2012 |Resource Link| KDAF-LTV

  12. Thanksgiving!

    Tags: Kourtney Kardashian, Elin Nordegren, Heart Attack Grill, Soleil Moon Frye, Zac Efron

 1  2 3 • Next >
Original site for Bevacizumab (drug) topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Bevacizumab (drug) Photos
A sign is displayed in front of the Genentech headquart...
(December 13, 2012)
A sign is displayed in front of the Genentech headquarters July 14, 2008 in South San Francisco, California. This company relied on the popularity of its cancer drug Avastin to boost profits.
, saying studies have failed to prove the drug's effect...
(July 1, 2011)
FDA panel rejects Avastin for breast cancer, but Medicare will still pay for it -- and Provenge
FDA's withdrawal will likely mean insurance companies w...
(June 29, 2011)
Avastin